Product sales
Our complementary healthcare businesses address the changing needs of patients and societies worldwide. With innovative pharmaceuticals at the core, we are also a global leader in generics, vaccines and consumer health products.
We believe this targeted portfolio best meets the challenges and opportunities in a dynamically changing healthcare environment.
Read more about the sales of our products.
| View by: |
| Product | Full Year 2007 Product Sales | Indication / Therapeutic Area | |
|---|---|---|---|
| USD m | variance in USD | ||
 |
5012 | 19% | Hypertension / Cardiovascular Metabolism and Endocrinology |
|
|||
 |
3050 | 19% | Chronic myeloid leukemia / Oncology Hematology |
|
|||
 |
748 | -45% | Hypertension / Cardiovascular Metabolism and Endocrinology |
|
|||
 |
1297 | 1% | Cancer complications / Oncology Hematology |
|
|||
 |
595 | -39% | Fungal infections / Dermatology |
|
|||
 |
937 | 30% | Breast cancer / Oncology Hematology |
|
|||
 |
692 | -4% | Epilepsy / Central Nervous System |
|
|||
 |
632 | 20% | Alzheimer's disease / Central Nervous System |
|
|||
 |
413 | 6% | Epilepsy / Central Nervous System |
|
|||
 |
420 | 24% | Parkinson's disease / Central Nervous System |
|
|||
| Ritalin | 375 | 14% | Attention deficit disorder / Central Nervous System |
|
|||
 |
393 | NM* | Age-related macular degeneration / Ophthalmics |
|
|||
 |
665 | -8% | Cholesterol reduction / Cardiovascular Metabolism and Endocrinology |
|
|||
 |
362 | 9% | Asthma / Respiratory |
|
|||
 |
944 | 3% | Transplantation / Transplantation |
|
|||
 |
1027 | 12% | Acromegaly / Oncology Hematology |
|
|||
 |
357 | 150% | Iron chelator / Oncology Hematology |
|
|||
 |
747 | 8% | Inflammation / pain / Rheumatology Bone and Hormone Replacement Therapy |
|
|||
 |
281 | -17% | Osteoporosis / Rheumatology Bone and Hormone Replacement Therapy |
|
|||
| Tobramycin | 273 | 54% | Cystic Fibrosis |
Corporate publications
